In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 213 for your search:
Cancer Type/Condition:  Esophageal cancer
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000454401, GERCOR-TAUROX, SANOFI-GERCOR-TAUROX, EU-20573, NCT00274885

2.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: CMNa-ESO-01-2007, NCT00642239

3.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: 06-14034, NCT00628784

4.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: AGIM-1, NCT01038154

5.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML25477, NCT01260194

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: R-09-025, NCT00907543

7.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 0291-1crgi09, NCT01348217

8.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 2010ESO_FU, NCT01402180

9.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: CDHA 147937-7, NCT01404156

10.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: ESCC001, NCT01704690

11.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Approved-not yet active
Age: Over 18 to 70
Sponsor: Other
Protocol IDs: 91-03-33-18878, NCT01829178

12.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: TMH 111/IM-2004, DAECTC/Projno 5 / 2004-05, NCT00193817

13.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: Shixiu - 1, NCT00686114

14.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: WCH-RCT-001, NCT01053182

15.

Phase: Phase III
Type: Treatment
Status: Active
Age: 70 and other
Sponsor: Other
Protocol IDs: 2007044, NCT01137123

16.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02601, CDR0000683717, RTOG 1010, U10CA021661, NCT01196390

17.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: 2007048, NCT01216527

18.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 30 to 75
Sponsor: Other
Protocol IDs: PKU-OES-001, NCT01361750

19.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2011ESO_FU_02, NCT01398449

20.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: AGC001-307PLAH-XJM, NCT01468389

21.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2011-1036, NCI-2012-00078, NCT01512589

22.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: NL35048.041.11, 11141, NCT01544790

23.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PS0058, NCT01572987

24.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ESO2012-01, NCT01591135

25.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: POWER / AIO-STO-0309, 2010-020606-15, NCT01627379
1     
New Search